News

Partnering supports novel DEL-screening capabilities Chemspace/Enamine positioned to augment product and service offerings Orogen to gain potential novel therapeutic small molecules Orogen Therapeutic ...
British pharmaceuticals giant AstraZeneca has revealed it plans to invest $50 billion (£37 billion) in America over the next ...
In a scientific first, researchers from Vanderbilt University and the University of California, San Diego, have generated a ...
A resonance effect can significantly affect how a three-atom molecule cools down when excited, RIKEN physicists have found.
Americans have been clamoring for sensible prescription drug reform for years. With the stroke of his pen, President Donald Trump answered that call. His executive order aims to bring down drug prices ...
AstraZeneca announces $50B US investment by 2030, creating thousands of jobs and building its largest drug manufacturing facility in Virginia.
The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The ...
Virginia facility investment will be AstraZeneca’s largest yet. Maryland, Massachusetts, California, Indiana, Texas projects ...
The Huck Institutes of the Life Sciences at Penn State has secured a major new asset in structural biology and mechanobiology ...
Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease that currently has no ...